Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Half year trading update

3 Aug 2015 07:00

RNS Number : 8042U
Toumaz Limited
03 August 2015
 



3 August 2015

 

Toumaz Limited

 

Half year trading update

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for digital audio and healthcare, provides the following trading update for the six months ended 30 June 2015. 

 

Financial highlights

 

· Revenues up 30% at £14.0m (H1 2014: £10.8m)

· Gross profit up 40% to £6.3m (H1 2014: £4.5m)

· EBITDA loss £5.5m (H1 2014: loss £5.6m)

· R&D expenditure: £6.4m (H1 2014: £5.1m)

· As at 30 June 2015, the cash balance was £5.5m (31 December 2015: £12.5 million)

 

Overview

 

The Digital Audio division has performed strongly with revenues up 34% at £13.8m (£10.3m in H1 2014). Growth has been driven by the international expansion of digital radio and the rapid emergence of the connected audio market. Toumaz is well-positioned in both sectors and the recent co-development agreement with Google is a strong endorsement of the Group's forthcoming next generation connected audio solution.

 

In Healthcare, the commercial delivery of SensiumVitals® remains slow with revenues of £0.2m (£0.5m in H1 2014); but based on recent trials the Board remains confident that the fundamental economic and clinical value of the system will be demonstrated.

 

Anthony Sethill, CEO of Toumaz, commented:

 

"We are delighted with the growth of our Digital Audio business. Our co-development agreement with Google will be an important factor in further developing our position in connected audio.

 

"We are trialling SensiumVitals® in a number of hospitals, including the Queen Elizabeth Hospital Birmingham and St James's Hospital, Leeds. However, these complex systems for the healthcare environment need considerable amounts of data and trialling, which have delayed our commercial roll out.

 

"Overall, given the strong performance by Digital Audio, we remain on course to continue to grow the business in the second half of the year."

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Euan Brown

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Chantal Woolcock

 

About Toumaz (www.toumaz.com)

 

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and digital audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRDAILVIE
Date   Source Headline
25th Sep 20177:00 amRNSChange of Adviser
21st Sep 20175:25 pmRNSNotification of Major Interest in Shares
8th Sep 20177:00 amRNSNotice of Results
1st Aug 20172:55 pmRNSTotal Voting Rights
27th Jul 20177:00 amRNSHalf Year Trading Update
30th Jun 20177:00 amRNSTotal Voting Rights
28th Jun 20174:41 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Jun 20174:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Jun 20172:45 pmRNSTotal Voting Rights
11th May 20173:30 pmRNSTR1: Notification of Major Interest in Shares
9th May 20179:48 amRNSResult of AGM
9th May 20177:00 amRNSNotification re discontinued business
5th May 20177:00 amRNSTrading update
10th Apr 20177:00 amRNSFrontier Silicon launches miniaturised DAB+ module
5th Apr 20177:00 amRNSBlock listing Interim Review
4th Apr 20173:10 pmRNSPosting of Annual Report and Notice of AGM
3rd Apr 20177:00 amRNSDesign win for Zound Industries 'Urban Ears'
24th Mar 20177:00 amRNSFinal Results
17th Mar 20175:10 pmRNSChange in ISIN
15th Mar 20177:00 amRNSMultiple design wins
3rd Mar 20177:00 amRNSNotice of Preliminary Results
7th Feb 20177:00 amRNSDirector Dealings and Grant of Options
26th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSAppointment of Non-Executive Director
25th Nov 201612:55 pmRNSTotal Voting Rights
1st Nov 20169:30 amRNSResult of EGM
7th Oct 20167:30 amRNSPosting of Circular & Notice of EGM
27th Sep 20167:00 amRNSInterim Results
14th Sep 20167:00 amRNSNotice of Results
13th Sep 20161:45 pmRNSTotal Voting Rights
2nd Sep 20167:00 amRNSDesign Win with World's Largest Speaker Company
29th Jul 20163:10 pmRNSDirectorate Change
22nd Jul 20167:00 amRNSSale of Healthcare division and trading update
26th May 201611:00 amRNSTotal Voting Rights
17th May 201610:38 amRNSResult of AGM
31st Mar 20161:01 pmRNSTotal Voting Rights
22nd Mar 20167:00 amRNSFull year results
18th Mar 20161:07 pmRNSBlock Listing Update
7th Mar 201612:01 pmRNSNotice of Results
29th Feb 20163:17 pmRNSTotal Voting Rights
25th Feb 20163:11 pmRNSHolding(s) in Company
22nd Feb 20164:07 pmRNSHolding(s) in Company
19th Feb 20163:51 pmRNSImagination Technologies Group plc stake
8th Feb 20164:11 pmRNSDirectorate Change
21st Jan 20167:00 amRNSYear-end trading update
20th Oct 20157:00 amRNSNew £5m banking facility
1st Oct 20157:00 amRNSFrontier Silicon powers ROBERTS R-Line audio range
30th Sep 20158:00 amRNSAmendment to terms of Director's share options
29th Sep 20157:00 amRNSHalf year results
24th Sep 20151:04 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.